Peer-influenced content. Sources you trust. No registration required. This is HCN.
Neurology Advisor
Age, a Critical Moderator in Anxiety/Depression and Cognitive Outcomes in MS In recent findings from the ACTRIMS Forum 2023, researchers underscored the crucial role of age in the relationship between mental health and cognitive outcomes in patients with multiple sclerosis (MS). Key Points: “Considering age is necessary when exploring the links between depression or anxiety and cognition in people with MS.” Researchers from the University of Toronto
Geriatrics June 13th 2023
Medical Professionals Reference (MPR)
The SSRI inhibitor was previously limited to adults. As physicians, we are continually seeking effective treatment options for our pediatric patients. The recent FDA approval of Lexapro for pediatric GAD treatment marks a significant advancement in this field.
Family Medicine/General Practice June 6th 2023
Harvard Medical School
Older adults using digital communications technology like email and video calls had higher levels of depression and anxiety about COVID-19. One explanation is that those who experiencing feelings of depression and anxiety were more likely to use digital tools. But another plausible explanation is that the digital technologies used were not well suited to older adults, possibly fueling their depression and anxiety.
Geriatrics April 25th 2023
ACP Internist
A young woman with ulcerative colitis in remission on 5-ASA and azathioprine is seen for annual follow up. Immunizations are current and her depression and anxiety screens are negative. Review her current status and select the most important health maintenance screen.
Family Medicine/General Practice March 15th 2023
MedPage Today
A 55-year-old woman has had slowly progressing speech distortion and problems with balance when walking. On exam, she showed signs of ataxia and chorea. Muscle tone was normal but stretch reflexes were absent. She had gaze-evoked horizontal nystagmus. Following electromyograph and MRI, and considering various conditions, her physicians proposed a diagnosis.
Neurology December 6th 2022
JAMA Network
The 8-week treatment with mindfulness-based stress reduction was a well-tolerated treatment option with comparable effectiveness to a first-line medication for patients with anxiety disorders in this randomized clinical trial of 276 adults with anxiety disorders.
Neurology November 14th 2022